Controversies in psychiatry and DSM-5: The relevance for social work (occasional essay)

Families in Society

Volumn 93, Issue 4, 2012, Pages 265-269

  Littrell, Jill ^a   Lacasse, Jeffrey R ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871907524     PISSN: 10443894     EISSN: None     Source Type: Journal    
DOI: 10.1606/1044-3894.4236     Document Type: Review

References (55)

1. Amminger, G. P., Schafter, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan,⋯ Berger, G. E. (2010). Long-chain ω-3 fatty acids for indicated prevention of psychotic disorders: A randomized, placebo-controlled trial. Archives of General Psychiatry, 67(2), 146-154.
2. Angell, M. (2005). The truth about drug companies: How they deceive us and what to do about it. New York, NY: Random House.
3. Angell, M. (2011a, June 23). Why there is an epidemic of mental illness. New York Review of Books, 1, 7/17(11), 20-22.
4. Angell, M. (2011b, July 14). The illusion of psychiatry. New York Review of Books, LVIII (12), 20-22.
5. Angell, M. (2011c, August 18). The illusion of psychiatry: An exchange. New York Review of Books, LVIII (13), 82-84.
6. Bentley, K. J., Walsh, J., & Farmer, R. L. (2005). Social work roles and activities regarding psychiatric medications: Results of a national survey. Social Work, 50(4), 295-303.
7. Blader, J. C., & Carlson, G. A. (2007). Increased rates of bipolar disorder diagnoses among U. S. child, adolescent, and adult inpatients, 1996-2004. Biological Psychiatry, 62(2), 107-114. (Pubitemid 46963252)
8. Bremner, J. D. (2011). The goose that laid the golden egg: Accutane-the truth that had to be told. UK: Nothing but Publishing.
9. Bodrova, E., & Leong, D. J. (1996). Tools of the mind: The Vygotskian approach to early childhood education. Columbus, OH: Merrill.
10. Carey, B. (2012, January 10). New definition of autism will exclude many, study suggests. New York Times. Retrieved from http://www.nytimes.com/2012/01/ 20/health/research/newautism-definition-would-exclude-many-study-suggests. html?pagewanted=all
11. Casey, D. E. (2006). Implications of the CATIE trial on treatment: Extrapyramidal symptoms. CNS Spectrum, 11(Suppl. 7), 25-31. (Pubitemid 44141226)
12. Clay, R. A. (2012). Improving disorder classification worldwide. Monitor on Psychology, 43(2), 40-44.
13. Cohen, J. A. (2003). Managed care and the evolving role of the clinical social worker in mental health. Social Work, 48(1), 34-43. (Pubitemid 38597584)
14. Comer, J. S., Mojtabai, R., & Olfson, M. (2011). National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. American Journal of Psychiatry 168(10), 1057-1065.
15. Cosgrove, L., & Krimsky, S. (2012). A comparison of the DSM-IV and DSM-5 panel members' financial associations with industry: A pernicious problem persists. PLoS Medicine, 9(3), el001190. doi: 10.1271/journal.pmed.l001190
16. Domino, M. E., & Swartz, M. S. (2008). Who are the new users of antipsychotic medications? Psychiatric Services, 59(5), 507-514.
17. dosReis, S., Yoon, Y, Rubin, D. M., Riddle, M. A., Noll, E., & Rothbard, A. (2011). Antipsychotic treatment among youth in foster care. Pediatrics, 128(6), 1459-1466.
18. Elliot, C. (2010). White coat, black hat: Adventures on the dark side of medicine. Boston, MA: Beacon Press.
19. Frances, A. (2009, June 26). A warning sign on the road to the DSM-V: Beware of its unintended consequences. Psychiatric Times, 26 (8). http://www.psychiatrictimes.com/display/article/10168/1425378
20. Frances, A. (2010, March 1). It's not too late to save "normal." Los Angeles Times. Retrieved from http://articles.latimes. com/2010/mar/01/opinion/la-oe-frances 1-2010mar01
21. Frances, A. (2011a, October). Debate: Does early intervention help or hinder mental health outcomes? Psychiatric Times, 28(10), 9-12.
22. Frances, A. (2011b, November 5). Allen Frances: Why psychiatrists should sign the petition to reform DSM-5: The fight for the future of psychiatry. Retrieved from http://societyforhumanisticpsychology.blogspot.com/2011/11/ allenfrances-why-psychiatrists-should.html
23. Frances, A. (2011c, November 10). The user's revolt against the DSM-5: Will it work? [Web log post] Psychiatric Times. Retrieved from http://www.psychiatrictimes.com/blog/dsm-5/content/article/10168/1988483
24. Gambrill, E. (2012). Propaganda in the helping professions. New York, NY: Oxford University Press.
25. Gomory, T., Wong, S. E., Cohen, D., & Lacasse, J. R. (2011). Clinical social work and the biomedical industrial complex. Journal of Sociology and Social Welfare, 38(4), 135-165.
26. Goodwin, F. K., & Jamison, K. R. (2007). Manic-depressive illness: Bipolar disorders and recurrent depression (2nd ed.). New York, NY: Oxford University Press.
27. Greenberg, G. (2010, December 27). Inside the battle to define mental illness. Retrieved from http://www.wired.com/magazine/2010/12/ff-dsmv
28. Harris, G., & Carey, B. (2008, July 12). Psychiatric association faces Senate scrutiny over drug industry ties. New York Times, p. A13.
29. Ho, B.-C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011). Long-term antipsychotic treatment and brain volume. Archives of General Psychiatry, 68(2), 128-137.
30. Horowitz, A., & Wakefield, J. C. (2007). The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York, NY: Oxford University Press.
31. Insel, T. R. (2009). Disruptive insights in psychiatry: Transforming a clinical discipline. Journal of Clinical Investigation, 119(14), 700-705.
32. Insel, T. R., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K.,⋯ Wang, P. (2010). Research Domain Criteria (RDoC): Toward a new classification framework for research on mental disorders. American Journal of Psychiatry, 167(7), 748-751.
33. Kawai, M., & Rosen, C. J. (2010). Minireview: A skeleton in serotonin's closet? Endocrinology, 15(9), 4103-4108.
34. Konopaske, G. T., Dorph-Petersen, K.-A., Pierri, J. N., Wu, Q., Sampson, A. R., & Lewis, D. A. (2007). Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of the macaque monkeys. Neuropsychopharmacology, 32, 1216-1223. (Pubitemid 46788845)
35. Konopaske, G. T., Dorph-Petersen, K.-A., Sweet, R. A., Pierri, J. N., Zhang, W., Sampson, A. R.,⋯ Lewis, D. A. (2008). Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biological Psychiatry, 63, 759-765. (Pubitemid 351400762)
36. Kutchins, H., & Kirk, S. A. (1992). The selling of the DSM: The rhetoric of science in psychiatry New York, NY: Aldine.
37. Lacasse, J. R., & Leo, J. (2010). Ghostwriting at elite academic medical centers in the United States. PLoS Medicine, 7(2), el000230.
38. Leslie, D. L., & Rosenheck, R. (2012). Off-label use of antipsychotic medications in Medicaid. American Journal of Managed Care, 18(3), e109-e117. PMID:22435962
39. Littrell, J., & Ashford, J. (1995). Can psychologists legally discuss medications with clients and when do they have a duty to do so? Professional Psychology: Research and Practice, 26, 238-244.
40. Littrell, J., & Lyons, P. (2010a). Pediatric bipolar disorder: An emerging issue. Children and Youth Services Review, 32(7), 945-964.
41. Littrell, J., & Lyons, P. (2010b). Pediatric bipolar disorder: An issue for child welfare. Children and Youth Services Review, 32(7), 965-973.
42. Marshall, M., & Rathbone, J. (2011). Early intervention for psychosis. Cochrane Data Base Systematic Reviews, 6, CD004187.
43. Mechanic, D. (2008). Mental health and social policy: Beyond managed care (5th ed.). New York, NY: Allyn & Bacon.
44. Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry, 64(9), 1032-1039. (Pubitemid 47360848)
45. Open letter to the DSM-5. (2011). Retrieved from the iPetitions website: http://www.ipetitions.com/petition/dsm5
46. Saleebey, D. (2001). The diagnostic strengths manual? Social Work, 46(2), 183-187.
47. Sinaikin, P. (2010). Psychiatryland. New York, NY: iUniverse.
48. Stahl, L. (Correspondent). (2012, February 19). Treating depression [segment of episode]. In R. Bonin (Producer), 60 Minutes. New York, NY: CBS News.
49. Stoesz, D. (2012). Book reviews. Research on Social Work Practice, 22(2), 243-246. doi:10.1177/1049731511419372
50. Thompson, A., Nelson, B., & Yung, A. (2011). Predictive validity of clinical variables in the "at risk" for psychosis population: International comparison with results from the North American Prodrome Longitudinal Study. Schizophrenia Research, 126(1-3), 51-57.
51. Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. The New England Journal of Medicine, 358, 252-260.
52. Turner, E. H., & Rosenthal, R. (2008). Efficacy of antidepressants. British Medical Journal, 336, 516-517.
53. U. S. Government Accountability Office testimony before the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, Committee on Homeland Security and Governmental Affairs, U. S. Senate, 112th Congress, 2011. Testimony of Gregory D. Kutz, Director of Forensic Audits and Investigative Service (GAO Report GAO-12-270T). Washington, DC: Author.
54. Whitaker, R. (2010). Anatomy of an epidemic. New York, NY: Crown.
55. Wilson, D. (2011, July 18). Heart warning added to label on popular antipsychotic drug. New York Times. Retrieved from http://www.nytimes.com/2011/ 07/19/health/19drug.html